Join Clinical Trials for Heart Disease
Heart disease refers to the many diseases affecting the heart. From congenital heart defects to coronary heart disease, there are many ongoing clinical trials for every form of heart disease.
Many forms of heart disease can actually be prevented or treated through behavioral interventions, so there are clinical trials attempting to evaluate prevention and treatment techniques.
There are also trials attempting to determine the prevalence of heart disease within various demographics to gain a better understanding of the epidemiology of this common condition.
Ultimately, clinical trials for heart disease are attempting to improve the quality of life of those afflicted with heart disease and to prevent those with increased risk from developing heart disease.
What will Heart Disease Clinical Trials be like?
Your eligibility must first be evaluated during a screening phase to ensure that you are the right fit for a heart disease trial. The goal of these trials is to improve the quality of life of those with heart disease, so inclusion criteria are intended to provide this benefit and avoid wasting your time.
Inclusion criteria are in place to avoid any risk from detrimental pharmaceutical interactions with another medication that you are taking. The researchers will therefore ask you to provide a very detailed medical history. In preventative trials, participants will be given a screening for heart disease risk factors.
Interventional trials will attempt to determine if you are an appropriate fit for a diverse array of new and improved treatment methods.
Typical Heart Disease Clinical Trial Protocol:
If the main interventional method being tested is a new pharmaceutical, you will be randomly assigned to a group that either receives the treatment or a placebo. To evaluate this intervention, participants will be asked to visit for follow up clinical assessments.
Behavioral intervention trials, such as exercise and dietary changes, will assign participants to different groups receiving various treatments or a standard control routine. Throughout the trial each group will be asked to attend follow up visits and testing to evaluate the success of the program.
Baseline measures of heart disease will be taken at the beginning of the trial, such as multi-detector computed tomographic angiography in coronary heart disease, for comparative monitoring purposes during checkpoints in the rest of the trial.
Studies aimed at enhancing the understanding of the various types of heart disease will request many questionnaires about an individual’s health and medical conditions, as well as physical examinations, clinical tests, and interviews.
These studies will help to provide a database of information for researchers to draw conclusions from to help make epidemiologic connections between risk factors and heart disease. Preventative trials will randomly assign participants to a group that will either receive the potential preventative treatment or a placebo.
Your participation in such trials provides critical insight into how this disease develops in at-risk individuals. Participation in all clinical trials for heart disease will enable researchers to improve the lives of those afflicted with heart disease and help prevent heart disease in others.
Suggested Search Terms:
Coronary Heart Disease, Cardiovascular Disease Screening, Genetics of Congenital Heart Defects, Women at Risk for Heart Disease, Exercise and Heart Disease
Current Search Term: